Efficacy of dupilumab for airway hypersecretion and airway wall thickening in patients with moderate-to-severe asthma: A prospective, observational study-Reference-Cited by-同舟云学术

Efficacy of dupilumab for airway hypersecretion and airway wall thickening in patients with moderate-to-severe asthma: A prospective, observational study

Published:2024-07 Issue:3 Volume:73 Page:406-415
ISSN:1323-8930
Container-title:Allergology International
language:en
Short-container-title:Allergology International

Author:

Tajiri Tomoko,Suzuki Motohiko,Nishiyama Hirono,Ozawa Yoshiyuki,Kurokawa Ryota,Takeda Norihisa,Ito Keima,Fukumitsu Kensuke,Kanemitsu Yoshihiro,Mori Yuta,Fukuda Satoshi,Uemura Takehiro,Ohkubo Hirotsugu,Takemura Masaya,Maeno Ken,Ito Yutaka,Oguri Tetsuya,Izuhara Kenji,Niimi Akio

Publisher

Elsevier BV

Reference60 articles.

1. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial;Wenzel;Lancet,2016

2. Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma;Castro;N Engl J Med,2018

3. Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study;Wechsler;Lancet Respir Med,2022

4. Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma;Rabe;N Engl J Med,2018

5. Dupilumab reduces oral corticosteroid use in patients with corticosteroid-dependent severe asthma: an analysis of the phase 3, open-label extension TRAVERSE trial;Sher;Chest,2022

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting dupilumab effectiveness with Type-2 biomarkers: A real-world study of severe asthma;Allergology International;2024-09

2. Dupilumab Improves Facial Pain and Reduces Rescue Treatments in Patients with CRSwNP and Recalcitrant Frontal Sinusitis;Journal of Personalized Medicine;2024-07-09

3. Type 2 severe asthma: pathophysiology and treatment with biologics;Expert Review of Respiratory Medicine;2024-07-02

4. Efficacy of dupilumab for severe chronic rhinosinusitis with nasal polyps and asthma;Annals of Allergy, Asthma & Immunology;2024-07

5. The Possible Roles of IL-4/IL-13 in the Development of Eosinophil-Predominant Severe Asthma;Biomolecules;2024-05-02